Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
LFCR
$6.51
+1.09%
LFCR
· Lifecore Biomedical, Inc. De
$6.51
+0.07 (+1.09%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$243.77M
Shares
37.85M
Volume · Oct 28
361.72K
Avg daily vol (3M)
351.48K
All webcasts
Earnings call · FY2021 Q2
Lifecore Biomedical, Inc. De (LFCR) Q2 2021 Earnings Call
Revenue
$23.79M
-83.3% YoY
Diluted EPS
-$0.40
Gross margin
45.3%
+34.4 pp YoY
Net income
-$11.62M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 6, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Jan 7, 2021 · complete as-filed document